LONDON MARKETS: Brexit Hopes Fuel Fresh Rally For The British Pound
October 11 2019 - 7:48AM
Dow Jones News
By Steve Goldstein, MarketWatch
U.K. banks stocks rise
Growing hopes that U.K. and European leaders can reach an agreed
deal for Britain to leave the European Union pushed the British
pound higher for a second day on Friday.
The pound rose to $1.2568, up from $1.2444 on Thursday, a day
when the U.K. currency had its best single day percentage advance
since March.
European Council President Donald Tusk -- who has tweeted
criticism at British Prime Minister Boris Johnson -- on Friday said
he received promising signals from Ireland's Leo Varadkar that a
deal is possible.
(https://twitter.com/eucopresident/status/1182581870363590656)
The Times newspaper reported that Johnson on Thursday gave some
ground on the issue of Northern Ireland.
The European Commission meanwhile said Michel Barnier had a
"constructive" meeting with Brexit Secretary Steve Barclay on
Friday.
"The change in tone yesterday from the Irish government and the
silence on the U.K. side indeed suggests the U.K. has made some
notable concessions," said analysts at Citi, who said they remained
skeptical a deal can be reached by Oct. 31, and that the more
likely path is an extension of the Article 50 deadline and a
general election.
The pound's strength weighed on U.K. stocks, as the FTSE 100
increased 0.32% to 7209.66, which isn't as strong as the rise made
by European rivals. Read Europe Markets
(http://www.marketwatch.com/story/hopes-for-trade-pact-buoy-european-stocks-as-publicis-and-hugo-boss-hit-by-warnings-2019-10-11)
The Brexit hopes did lift U.K. banks Royal Bank of Scotland
(RBS.LN) , which surged 12%, and Lloyds Banking Group (LLOY.LN) ,
which rose 10%. The big multinational pharmaceuticals lost ground,
with (GSK.LN) falling 4% and AstraZeneca (AZN.LN) losing 3.2%.
(END) Dow Jones Newswires
October 11, 2019 07:33 ET (11:33 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
GSK (NYSE:GSK)
Historical Stock Chart
From Aug 2024 to Sep 2024
GSK (NYSE:GSK)
Historical Stock Chart
From Sep 2023 to Sep 2024